Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
PLoS One ; 6(9): e23059, 2011.
Article in English | MEDLINE | ID: mdl-21969850

ABSTRACT

Postherpetic neuralgia (PHN), the most common complication of herpes zoster (HZ), plays a major role in decreased life quality of HZ patients. However, the neural mechanisms underlying PHN remain unclear. Here, using a PHN rat model at 2 weeks after varicella zoster virus infection, we found that spinal astrocytes were dramatically activated. The mechanical allodynia and spinal central sensitization were significantly attenuated by intrathecally injected L-α-aminoadipate (astrocytic specific inhibitor) whereas minocycline (microglial specific inhibitor) had no effect, which indicated that spinal astrocyte but not microglia contributed to the chronic pain in PHN rat. Further study was taken to investigate the molecular mechanism of astrocyte-incudced allodynia in PHN rat at post-infection 2 weeks. Results showed that nitric oxide (NO) produced by inducible nitric oxide synthase mediated the development of spinal astrocytic activation, and activated astrocytes dramatically increased interleukin-1ß expression which induced N-methyl-D-aspartic acid receptor (NMDAR) phosphorylation in spinal dorsal horn neurons to strengthen pain transmission. Taken together, these results suggest that spinal activated astrocytes may be one of the most important factors in the pathophysiology of PHN and "NO-Astrocyte-Cytokine-NMDAR-Neuron" pathway may be the detailed neural mechanisms underlying PHN. Thus, inhibiting spinal astrocytic activation may represent a novel therapeutic strategy for clinical management of PHN.


Subject(s)
Astrocytes/pathology , Neuralgia/pathology , Animals , Astrocytes/cytology , Disease Models, Animal , Electrophysiology/methods , Gene Expression Regulation , Herpes Zoster/pathology , Herpesvirus 3, Human/metabolism , Hyperalgesia/pathology , Interleukin-1beta/metabolism , Male , Microscopy, Fluorescence/methods , Nitric Oxide/metabolism , Rats , Rats, Wistar , Receptors, N-Methyl-D-Aspartate/metabolism , Time Factors
2.
Anat Rec (Hoboken) ; 294(4): 706-11, 2011 Apr.
Article in English | MEDLINE | ID: mdl-21365775

ABSTRACT

Recent studies indicated that G protein couple receptor 30 (GPR30), a nongenomic estrogen receptor, is widely expressed in many organ systems inducing many quick reaction of estrogen. However, there was rare report about the expression of GPR30 in the salivary gland. In the present study, we investigated the distribution of GPR30 in rat submaxillary gland by means of immunohistochemistry and in situ hybridization. GPR30 core sequences were amplified by RT-PCR with total RNA extracted from rat submaxillary gland and were analyzed by sequencing with Sanger's method. The results showed that the epithelial cells of serous alveoli and granular convoluted duct in rat submaxillary gland displayed GPR30-immunoreactivity on the plasma membrane and cytoplasm. Moreover, GPR30 mRNA hybridization signals were also detected in the cytoplasm of the above cells. GPR30 cDNA sequence cloned from rat submaxillary gland is identical to that of GPR30 from rat paraventricular and supraoptic nucleus. In conclusion, the expression of GPR30 in the serous and granular epithelial cells of submaxillary gland indicates that submaxillary gland could also be a target organ rapidly responding to estrogen stimulus, and estrogen may be involved in the functional regulation of submaxillary gland.


Subject(s)
Epithelial Cells/chemistry , Receptors, G-Protein-Coupled/analysis , Submandibular Gland/chemistry , Animals , Cell Membrane/chemistry , Cloning, Molecular , Cytoplasm/chemistry , Immunohistochemistry , In Situ Hybridization , Male , RNA, Messenger/analysis , Rats , Rats, Sprague-Dawley , Receptors, G-Protein-Coupled/chemistry , Receptors, G-Protein-Coupled/genetics , Receptors, G-Protein-Coupled/isolation & purification , Reverse Transcriptase Polymerase Chain Reaction , Sequence Analysis, DNA
3.
Brain Res ; 1368: 324-35, 2011 Jan 12.
Article in English | MEDLINE | ID: mdl-20971097

ABSTRACT

Diabetic neuropathic pain (DNP) plays a major role in decreased life quality of type 2 diabetes patients, however, the molecular mechanisms underlying DNP remain unclear. Emerging research implicates the participation of spinal glial cells in some neuropathic pain models. However, it remains unknown whether spinal glial cells are activated under type 2 diabetic conditions and whether they contribute to diabetes-induced neuropathic pain. In the present study, using a db/db type 2 diabetes mouse model that displayed obvious mechanical allodynia, we found that spinal astrocyte but not microglia was dramatically activated. The mechanical allodynia was significantly attenuated by intrathecally administrated l-α-aminoadipate (astrocytic specific inhibitor) whereas minocycline (microglial specific inhibitor) did not have any effect on mechanical allodynia, which indicated that spinal astrocytic activation contributed to allodynia in db/db mice. Further study aimed to identify the detailed mechanism of astrocyte-induced allodynia in db/db mice. Results showed that spinal activated astrocytes dramatically increased interleukin (IL)-1ß expression which may induce N-methyl-D-aspartic acid receptor (NMDAR) phosphorylation in spinal dorsal horn neurons to enhance pain transmission. Together, these results suggest that spinal activated astrocytes may be a crucial component of mechanical allodynia in type 2 diabetes and "Astrocyte-IL-1ß-NMDAR-Neuron" pathway may be the detailed mechanism of astrocyte-induced allodynia. Thus, inhibiting astrocytic activation in the spinal dorsal horn may represent a novel therapeutic strategy for treating DNP.


Subject(s)
Astrocytes/metabolism , Diabetes Mellitus, Type 2/physiopathology , Diabetic Neuropathies/metabolism , Hyperalgesia/metabolism , 2-Aminoadipic Acid/administration & dosage , 2-Aminoadipic Acid/pharmacology , Animals , Astrocytes/drug effects , Diabetes Mellitus, Type 2/complications , Diabetic Neuropathies/etiology , Disease Models, Animal , Excitatory Amino Acid Antagonists/administration & dosage , Excitatory Amino Acid Antagonists/pharmacology , Hyperalgesia/drug therapy , Hyperalgesia/etiology , Injections, Spinal , Interleukin-1beta/metabolism , Mice , Mice, Inbred C57BL , Minocycline/administration & dosage , Minocycline/pharmacology , Pain Measurement/methods , Spinal Cord/cytology , Spinal Cord/metabolism , Treatment Outcome
4.
J Ind Microbiol Biotechnol ; 35(1): 41-7, 2008 Jan.
Article in English | MEDLINE | ID: mdl-17943333

ABSTRACT

Effects of the enzymes in Actinomucor elegans extract and the enzyme Alcalase 2.4L on debittering the soybean protein hydrolysates were investigated. When the protein was treated only with the latter, a strong bitterness formed; but it decreased if the protein was treated with both the enzymes. The more the enzymes were used, weaker was the bitterness tasted. SDS-PAGE profile and ESI-MS spectrum of the hydrolysates evidenced that the Alcalase could convert the protein into peptides rapidly, while the enzymes in the A. elegans extract were able to further degrade some peptides which were difficult or unable to be hydrolyzed by the Alcalase. Further systematic analysis of the peptidases showed that the Alcalase exhibited a significant endopeptidase activity towards NBZ-Phe-pNA substrate (p < 0.01), whereas many exopeptidases in the A. elegans extract had the carboxypeptidase activity towards N-CBZ-Ile-Leu (p < 0.01). It is concluded that those exopeptidases presented in the A. elegans extract can benefit by decreasing the bitterness of the soybean protein hydroysate. They are also capable of being used with the Alcalase in a single-step enzymatic reaction to prepare the bitterless protein hydrolysate, which may be an efficient application for food industry.


Subject(s)
Mucorales/enzymology , Peptide Hydrolases/metabolism , Protein Hydrolysates/chemistry , Soybean Proteins/metabolism , Taste , Adult , Endopeptidases/metabolism , Exopeptidases/metabolism , Female , Food Industry/methods , Humans , Male , Protein Hydrolysates/metabolism , Subtilisins/metabolism , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...